Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?

被引：6
|
作者：
Ravenstijn, Paulien [1 ]
Samtani, Mahesh [2 ]
Russu, Alberto [1 ]
Hough, David [3 ]
Gopal, Srihari [3 ]
机构：
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 06期
关键词：
SCHIZOPHRENIA; INJECTIONS;
D O I：
10.1097/JCP.0000000000000610
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：744 / 745
页数：2
相关论文
共 50 条
  • [41] Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
    Sylvain Druais
    Agathe Doutriaux
    Magali Cognet
    Annabelle Godet
    Christophe Lançon
    Pierre Levy
    Ludovic Samalin
    Pascal Guillon
    PharmacoEconomics, 2016, 34 : 363 - 391
  • [42] Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting
    Hodgson, Richard E.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 517 - 524
  • [43] A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic
    Lai, Jonathan K.
    Margolese, Howard C.
    SCHIZOPHRENIA RESEARCH, 2019, 204 : 443 - 444
  • [44] Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization
    Taylor, David
    Olofinjana, Olubanke
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (04) : 229 - 234
  • [45] A case report of pregnancy and paliperidone palmitate 3-monthly long-acting injection
    de Azevedo Avelar, Rita
    Luengo Corbal, Antonio
    Heitor, Maria Joao
    CLINICAL CASE REPORTS, 2020, 8 (12): : 2592 - 2594
  • [46] The impact of paliperidone palmitate long-acting injection on hospital admissions in a mental health setting
    Nikolic, Nikola
    Page, Natalie
    Akram, Adil
    Khan, Maha
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 95 - 102
  • [47] Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy
    Ravasio, Roberto
    Nicole, Giuseppe
    Vaggi, Marco
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (01) : 17 - 32
  • [48] Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics
    Hargarter, Ludger
    Cherubin, Pierre
    Bergmans, Paul
    Keim, Sofia
    Rancans, Elmars
    Bez, Yasin
    Parellad, Eduard
    Carpiniello, Bernardo
    Vidailhet, Pierre
    Schreiner, Andreas
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 58 : 1 - 7
  • [49] A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
    Najarian, Dean
    Sanga, Panna
    Wang, Steven
    Lim, Pilar
    Singh, Arun
    Robertson, Mary Jane
    Cohen, Kristin
    Schotte, Alain
    Milz, Ruth
    Venkatasubramanian, Raja
    T'Jollyn, Huybrecht
    Walling, David P.
    Galderisi, Silvana
    Gopal, Srihari
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (03): : 238 - 251
  • [50] Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer K.
    Ma, Yi-Wen
    Alphs, Larry
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (01) : 45 - 55
12345